Literature DB >> 20827227

Comparison of 18F-FDG and 11C-choline PET/CT for detecting recurrences in patients with nonsquamous cell head and neck malignancies.

Kimiteru Ito1, Jyunkichi Yokoyama, Kazuo Kubota, Miyako Morooka.   

Abstract

OBJECTIVE: The aim of this retrospective study was to evaluate the usefulness of F-fluorodeoxyglucose (FDG) and C-choline positron emission tomography (PET)/computed tomography (CT) for detecting recurrences of nonsquamous cell head and neck malignancies after chemotherapy and radiotherapy.
METHOD: Fourteen patients (10 men and four women; mean age: 53.7 ± 14.5 years) with advanced nonsquamous cell head and neck malignancies other than squamous cell carcinoma were recruited. F-FDG and C-choline PET/CT examinations were performed in all the patients after chemotherapy and radiotherapy. The PET/CT images were evaluated using a visual analysis and a region-based analysis. After the posttreatment PET/CT examination, all the patients underwent further surveillance using the conventional imaging methods.
RESULTS: Recurrences were eventually confirmed in eight patients after the posttreatment PET/CT examination. The region-based analysis showed that the maximum standardized uptake values for F-FDG and C-choline were strongly correlated with each other (R=0.84). The C-choline PET/CT clearly detected the lesions in two patients, one with severe diabetes mellitus and one with a brain lesion.
CONCLUSION: The abilities of F-FDG and C-choline PET/CT to detect lesions were almost the same in this study. In addition, choline has a superior potential for imaging skull base and intracranial lesions because the normal brain is not choline avid.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20827227     DOI: 10.1097/MNM.0b013e32833f3921

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  6 in total

1.  Prognostic value of post-treatment (18)F-FDG PET/CT for advanced head and neck cancer after combined intra-arterial chemotherapy and radiotherapy.

Authors:  Kimiteru Ito; Keigo Shimoji; Yoko Miyata; Kouhei Kamiya; Ryogo Minamimoto; Kazuo Kubota; Momoko Okasaki; Miyako Morooka; Jyunkichi Yokoyama
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

Review 2.  Alternative PET tracers in head and neck cancer. A review.

Authors:  Jan Wedman; Jan Pruim; Jan L N Roodenburg; Gyorgy B Halmos; Johannes A Langedijk; Rudi A J O Dierckx; Bernard F A M van der Laan
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-27       Impact factor: 2.503

3.  (11)C-choline PET/CT tumor recurrence detection and survival prediction in post-treatment patients with high-grade gliomas.

Authors:  Wanhu Li; Li Ma; Xiaoyue Wang; Jujie Sun; Suzhen Wang; Xudong Hu
Journal:  Tumour Biol       Date:  2014-09-03

4.  Is C-11 Methionine PET an alternative to 18-F FDG-PET for identifying recurrent laryngeal cancer after radiotherapy?

Authors:  Jan Wedman; Jan Pruim; Lisa van der Putten; Otto S Hoekstra; Remco de Bree; Boukje A C van Dijk; Bernard F A M van der Laan
Journal:  Clin Otolaryngol       Date:  2018-11-18       Impact factor: 2.597

5.  Tracers progress for positron emission tomography imaging of glial-related disease.

Authors:  Haoran Jia; Tianwu Xie
Journal:  J Biomed Res       Date:  2022-06-28

6.  Positive and Negative Predictive Value of PET-CT in Skull Base Lesions: Case Series and Systematic Literature Review.

Authors:  John Peyton Hines; Brittany E Howard; Joseph M Hoxworth; Devyani Lal
Journal:  J Neurol Surg Rep       Date:  2016-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.